no. biosante was to have met with the FDA to discuss the failed trials. still waiting for them to advise on the minutes of that meeting. could be any day.
If they stop the safety trial--which was mentioned as a possibility in the earnings PR--it will definitely be dead. Simes has obviously not yet made up his mind.